Global Drug Discovery and Preclinical CRO Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Drug Discovery and Preclinical CRO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Drug Discovery and Preclinical CRO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Drug Discovery and Preclinical CRO market in any manner.
Global Drug Discovery and Preclinical CRO Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Charles River
Wuxi AppTec
Labcorp
Eurofins Scientific
PPD
ICON plc
Pharmaron
Inotiv
ChemPartner
JOINN Laboratories
Evotec
Medicilon
Crown Bioscience
Champions Oncology
Frontage Laboratories
Viva Biotech
Hitgen Inc.
Shanghai Innostar
Market Segmentation (by Type)
Drug Discovery
Preclinical Research
Market Segmentation (by Application)
Pharmaceutical Company
Biotech Company
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug Discovery and Preclinical CRO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Drug Discovery and Preclinical CRO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Drug Discovery and Preclinical CRO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Drug Discovery and Preclinical CRO market in any manner.
Global Drug Discovery and Preclinical CRO Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Charles River
Wuxi AppTec
Labcorp
Eurofins Scientific
PPD
ICON plc
Pharmaron
Inotiv
ChemPartner
JOINN Laboratories
Evotec
Medicilon
Crown Bioscience
Champions Oncology
Frontage Laboratories
Viva Biotech
Hitgen Inc.
Shanghai Innostar
Market Segmentation (by Type)
Drug Discovery
Preclinical Research
Market Segmentation (by Application)
Pharmaceutical Company
Biotech Company
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Drug Discovery and Preclinical CRO Market
- Overview of the regional outlook of the Drug Discovery and Preclinical CRO Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drug Discovery and Preclinical CRO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Drug Discovery and Preclinical CRO
1.2 Key Market Segments
1.2.1 Drug Discovery and Preclinical CRO Segment by Type
1.2.2 Drug Discovery and Preclinical CRO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DRUG DISCOVERY AND PRECLINICAL CRO MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DRUG DISCOVERY AND PRECLINICAL CRO MARKET COMPETITIVE LANDSCAPE
3.1 Global Drug Discovery and Preclinical CRO Revenue Market Share by Company (2019-2024)
3.2 Drug Discovery and Preclinical CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Drug Discovery and Preclinical CRO Market Size Sites, Area Served, Product Type
3.4 Drug Discovery and Preclinical CRO Market Competitive Situation and Trends
3.4.1 Drug Discovery and Preclinical CRO Market Concentration Rate
3.4.2 Global 5 and 10 Largest Drug Discovery and Preclinical CRO Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 DRUG DISCOVERY AND PRECLINICAL CRO VALUE CHAIN ANALYSIS
4.1 Drug Discovery and Preclinical CRO Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DRUG DISCOVERY AND PRECLINICAL CRO MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 DRUG DISCOVERY AND PRECLINICAL CRO MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drug Discovery and Preclinical CRO Market Size Market Share by Type (2019-2024)
6.3 Global Drug Discovery and Preclinical CRO Market Size Growth Rate by Type (2019-2024)
7 DRUG DISCOVERY AND PRECLINICAL CRO MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drug Discovery and Preclinical CRO Market Size (M USD) by Application (2019-2024)
7.3 Global Drug Discovery and Preclinical CRO Market Size Growth Rate by Application (2019-2024)
8 DRUG DISCOVERY AND PRECLINICAL CRO MARKET SEGMENTATION BY REGION
8.1 Global Drug Discovery and Preclinical CRO Market Size by Region
8.1.1 Global Drug Discovery and Preclinical CRO Market Size by Region
8.1.2 Global Drug Discovery and Preclinical CRO Market Size Market Share by Region
8.2 North America
8.2.1 North America Drug Discovery and Preclinical CRO Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Drug Discovery and Preclinical CRO Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Drug Discovery and Preclinical CRO Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Drug Discovery and Preclinical CRO Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Drug Discovery and Preclinical CRO Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Charles River
9.1.1 Charles River Drug Discovery and Preclinical CRO Basic Information
9.1.2 Charles River Drug Discovery and Preclinical CRO Product Overview
9.1.3 Charles River Drug Discovery and Preclinical CRO Product Market Performance
9.1.4 Charles River Drug Discovery and Preclinical CRO SWOT Analysis
9.1.5 Charles River Business Overview
9.1.6 Charles River Recent Developments
9.2 Wuxi AppTec
9.2.1 Wuxi AppTec Drug Discovery and Preclinical CRO Basic Information
9.2.2 Wuxi AppTec Drug Discovery and Preclinical CRO Product Overview
9.2.3 Wuxi AppTec Drug Discovery and Preclinical CRO Product Market Performance
9.2.4 Charles River Drug Discovery and Preclinical CRO SWOT Analysis
9.2.5 Wuxi AppTec Business Overview
9.2.6 Wuxi AppTec Recent Developments
9.3 Labcorp
9.3.1 Labcorp Drug Discovery and Preclinical CRO Basic Information
9.3.2 Labcorp Drug Discovery and Preclinical CRO Product Overview
9.3.3 Labcorp Drug Discovery and Preclinical CRO Product Market Performance
9.3.4 Charles River Drug Discovery and Preclinical CRO SWOT Analysis
9.3.5 Labcorp Business Overview
9.3.6 Labcorp Recent Developments
9.4 Eurofins Scientific
9.4.1 Eurofins Scientific Drug Discovery and Preclinical CRO Basic Information
9.4.2 Eurofins Scientific Drug Discovery and Preclinical CRO Product Overview
9.4.3 Eurofins Scientific Drug Discovery and Preclinical CRO Product Market Performance
9.4.4 Eurofins Scientific Business Overview
9.4.5 Eurofins Scientific Recent Developments
9.5 PPD
9.5.1 PPD Drug Discovery and Preclinical CRO Basic Information
9.5.2 PPD Drug Discovery and Preclinical CRO Product Overview
9.5.3 PPD Drug Discovery and Preclinical CRO Product Market Performance
9.5.4 PPD Business Overview
9.5.5 PPD Recent Developments
9.6 ICON plc
9.6.1 ICON plc Drug Discovery and Preclinical CRO Basic Information
9.6.2 ICON plc Drug Discovery and Preclinical CRO Product Overview
9.6.3 ICON plc Drug Discovery and Preclinical CRO Product Market Performance
9.6.4 ICON plc Business Overview
9.6.5 ICON plc Recent Developments
9.7 Pharmaron
9.7.1 Pharmaron Drug Discovery and Preclinical CRO Basic Information
9.7.2 Pharmaron Drug Discovery and Preclinical CRO Product Overview
9.7.3 Pharmaron Drug Discovery and Preclinical CRO Product Market Performance
9.7.4 Pharmaron Business Overview
9.7.5 Pharmaron Recent Developments
9.8 Inotiv
9.8.1 Inotiv Drug Discovery and Preclinical CRO Basic Information
9.8.2 Inotiv Drug Discovery and Preclinical CRO Product Overview
9.8.3 Inotiv Drug Discovery and Preclinical CRO Product Market Performance
9.8.4 Inotiv Business Overview
9.8.5 Inotiv Recent Developments
9.9 ChemPartner
9.9.1 ChemPartner Drug Discovery and Preclinical CRO Basic Information
9.9.2 ChemPartner Drug Discovery and Preclinical CRO Product Overview
9.9.3 ChemPartner Drug Discovery and Preclinical CRO Product Market Performance
9.9.4 ChemPartner Business Overview
9.9.5 ChemPartner Recent Developments
9.10 JOINN Laboratories
9.10.1 JOINN Laboratories Drug Discovery and Preclinical CRO Basic Information
9.10.2 JOINN Laboratories Drug Discovery and Preclinical CRO Product Overview
9.10.3 JOINN Laboratories Drug Discovery and Preclinical CRO Product Market Performance
9.10.4 JOINN Laboratories Business Overview
9.10.5 JOINN Laboratories Recent Developments
9.11 Evotec
9.11.1 Evotec Drug Discovery and Preclinical CRO Basic Information
9.11.2 Evotec Drug Discovery and Preclinical CRO Product Overview
9.11.3 Evotec Drug Discovery and Preclinical CRO Product Market Performance
9.11.4 Evotec Business Overview
9.11.5 Evotec Recent Developments
9.12 Medicilon
9.12.1 Medicilon Drug Discovery and Preclinical CRO Basic Information
9.12.2 Medicilon Drug Discovery and Preclinical CRO Product Overview
9.12.3 Medicilon Drug Discovery and Preclinical CRO Product Market Performance
9.12.4 Medicilon Business Overview
9.12.5 Medicilon Recent Developments
9.13 Crown Bioscience
9.13.1 Crown Bioscience Drug Discovery and Preclinical CRO Basic Information
9.13.2 Crown Bioscience Drug Discovery and Preclinical CRO Product Overview
9.13.3 Crown Bioscience Drug Discovery and Preclinical CRO Product Market Performance
9.13.4 Crown Bioscience Business Overview
9.13.5 Crown Bioscience Recent Developments
9.14 Champions Oncology
9.14.1 Champions Oncology Drug Discovery and Preclinical CRO Basic Information
9.14.2 Champions Oncology Drug Discovery and Preclinical CRO Product Overview
9.14.3 Champions Oncology Drug Discovery and Preclinical CRO Product Market Performance
9.14.4 Champions Oncology Business Overview
9.14.5 Champions Oncology Recent Developments
9.15 Frontage Laboratories
9.15.1 Frontage Laboratories Drug Discovery and Preclinical CRO Basic Information
9.15.2 Frontage Laboratories Drug Discovery and Preclinical CRO Product Overview
9.15.3 Frontage Laboratories Drug Discovery and Preclinical CRO Product Market Performance
9.15.4 Frontage Laboratories Business Overview
9.15.5 Frontage Laboratories Recent Developments
9.16 Viva Biotech
9.16.1 Viva Biotech Drug Discovery and Preclinical CRO Basic Information
9.16.2 Viva Biotech Drug Discovery and Preclinical CRO Product Overview
9.16.3 Viva Biotech Drug Discovery and Preclinical CRO Product Market Performance
9.16.4 Viva Biotech Business Overview
9.16.5 Viva Biotech Recent Developments
9.17 Hitgen Inc.
9.17.1 Hitgen Inc. Drug Discovery and Preclinical CRO Basic Information
9.17.2 Hitgen Inc. Drug Discovery and Preclinical CRO Product Overview
9.17.3 Hitgen Inc. Drug Discovery and Preclinical CRO Product Market Performance
9.17.4 Hitgen Inc. Business Overview
9.17.5 Hitgen Inc. Recent Developments
9.18 Shanghai Innostar
9.18.1 Shanghai Innostar Drug Discovery and Preclinical CRO Basic Information
9.18.2 Shanghai Innostar Drug Discovery and Preclinical CRO Product Overview
9.18.3 Shanghai Innostar Drug Discovery and Preclinical CRO Product Market Performance
9.18.4 Shanghai Innostar Business Overview
9.18.5 Shanghai Innostar Recent Developments
10 DRUG DISCOVERY AND PRECLINICAL CRO REGIONAL MARKET FORECAST
10.1 Global Drug Discovery and Preclinical CRO Market Size Forecast
10.2 Global Drug Discovery and Preclinical CRO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Drug Discovery and Preclinical CRO Market Size Forecast by Country
10.2.3 Asia Pacific Drug Discovery and Preclinical CRO Market Size Forecast by Region
10.2.4 South America Drug Discovery and Preclinical CRO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Drug Discovery and Preclinical CRO by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Drug Discovery and Preclinical CRO Market Forecast by Type (2025-2030)
11.2 Global Drug Discovery and Preclinical CRO Market Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Drug Discovery and Preclinical CRO
1.2 Key Market Segments
1.2.1 Drug Discovery and Preclinical CRO Segment by Type
1.2.2 Drug Discovery and Preclinical CRO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DRUG DISCOVERY AND PRECLINICAL CRO MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DRUG DISCOVERY AND PRECLINICAL CRO MARKET COMPETITIVE LANDSCAPE
3.1 Global Drug Discovery and Preclinical CRO Revenue Market Share by Company (2019-2024)
3.2 Drug Discovery and Preclinical CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Drug Discovery and Preclinical CRO Market Size Sites, Area Served, Product Type
3.4 Drug Discovery and Preclinical CRO Market Competitive Situation and Trends
3.4.1 Drug Discovery and Preclinical CRO Market Concentration Rate
3.4.2 Global 5 and 10 Largest Drug Discovery and Preclinical CRO Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 DRUG DISCOVERY AND PRECLINICAL CRO VALUE CHAIN ANALYSIS
4.1 Drug Discovery and Preclinical CRO Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DRUG DISCOVERY AND PRECLINICAL CRO MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 DRUG DISCOVERY AND PRECLINICAL CRO MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drug Discovery and Preclinical CRO Market Size Market Share by Type (2019-2024)
6.3 Global Drug Discovery and Preclinical CRO Market Size Growth Rate by Type (2019-2024)
7 DRUG DISCOVERY AND PRECLINICAL CRO MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drug Discovery and Preclinical CRO Market Size (M USD) by Application (2019-2024)
7.3 Global Drug Discovery and Preclinical CRO Market Size Growth Rate by Application (2019-2024)
8 DRUG DISCOVERY AND PRECLINICAL CRO MARKET SEGMENTATION BY REGION
8.1 Global Drug Discovery and Preclinical CRO Market Size by Region
8.1.1 Global Drug Discovery and Preclinical CRO Market Size by Region
8.1.2 Global Drug Discovery and Preclinical CRO Market Size Market Share by Region
8.2 North America
8.2.1 North America Drug Discovery and Preclinical CRO Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Drug Discovery and Preclinical CRO Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Drug Discovery and Preclinical CRO Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Drug Discovery and Preclinical CRO Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Drug Discovery and Preclinical CRO Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Charles River
9.1.1 Charles River Drug Discovery and Preclinical CRO Basic Information
9.1.2 Charles River Drug Discovery and Preclinical CRO Product Overview
9.1.3 Charles River Drug Discovery and Preclinical CRO Product Market Performance
9.1.4 Charles River Drug Discovery and Preclinical CRO SWOT Analysis
9.1.5 Charles River Business Overview
9.1.6 Charles River Recent Developments
9.2 Wuxi AppTec
9.2.1 Wuxi AppTec Drug Discovery and Preclinical CRO Basic Information
9.2.2 Wuxi AppTec Drug Discovery and Preclinical CRO Product Overview
9.2.3 Wuxi AppTec Drug Discovery and Preclinical CRO Product Market Performance
9.2.4 Charles River Drug Discovery and Preclinical CRO SWOT Analysis
9.2.5 Wuxi AppTec Business Overview
9.2.6 Wuxi AppTec Recent Developments
9.3 Labcorp
9.3.1 Labcorp Drug Discovery and Preclinical CRO Basic Information
9.3.2 Labcorp Drug Discovery and Preclinical CRO Product Overview
9.3.3 Labcorp Drug Discovery and Preclinical CRO Product Market Performance
9.3.4 Charles River Drug Discovery and Preclinical CRO SWOT Analysis
9.3.5 Labcorp Business Overview
9.3.6 Labcorp Recent Developments
9.4 Eurofins Scientific
9.4.1 Eurofins Scientific Drug Discovery and Preclinical CRO Basic Information
9.4.2 Eurofins Scientific Drug Discovery and Preclinical CRO Product Overview
9.4.3 Eurofins Scientific Drug Discovery and Preclinical CRO Product Market Performance
9.4.4 Eurofins Scientific Business Overview
9.4.5 Eurofins Scientific Recent Developments
9.5 PPD
9.5.1 PPD Drug Discovery and Preclinical CRO Basic Information
9.5.2 PPD Drug Discovery and Preclinical CRO Product Overview
9.5.3 PPD Drug Discovery and Preclinical CRO Product Market Performance
9.5.4 PPD Business Overview
9.5.5 PPD Recent Developments
9.6 ICON plc
9.6.1 ICON plc Drug Discovery and Preclinical CRO Basic Information
9.6.2 ICON plc Drug Discovery and Preclinical CRO Product Overview
9.6.3 ICON plc Drug Discovery and Preclinical CRO Product Market Performance
9.6.4 ICON plc Business Overview
9.6.5 ICON plc Recent Developments
9.7 Pharmaron
9.7.1 Pharmaron Drug Discovery and Preclinical CRO Basic Information
9.7.2 Pharmaron Drug Discovery and Preclinical CRO Product Overview
9.7.3 Pharmaron Drug Discovery and Preclinical CRO Product Market Performance
9.7.4 Pharmaron Business Overview
9.7.5 Pharmaron Recent Developments
9.8 Inotiv
9.8.1 Inotiv Drug Discovery and Preclinical CRO Basic Information
9.8.2 Inotiv Drug Discovery and Preclinical CRO Product Overview
9.8.3 Inotiv Drug Discovery and Preclinical CRO Product Market Performance
9.8.4 Inotiv Business Overview
9.8.5 Inotiv Recent Developments
9.9 ChemPartner
9.9.1 ChemPartner Drug Discovery and Preclinical CRO Basic Information
9.9.2 ChemPartner Drug Discovery and Preclinical CRO Product Overview
9.9.3 ChemPartner Drug Discovery and Preclinical CRO Product Market Performance
9.9.4 ChemPartner Business Overview
9.9.5 ChemPartner Recent Developments
9.10 JOINN Laboratories
9.10.1 JOINN Laboratories Drug Discovery and Preclinical CRO Basic Information
9.10.2 JOINN Laboratories Drug Discovery and Preclinical CRO Product Overview
9.10.3 JOINN Laboratories Drug Discovery and Preclinical CRO Product Market Performance
9.10.4 JOINN Laboratories Business Overview
9.10.5 JOINN Laboratories Recent Developments
9.11 Evotec
9.11.1 Evotec Drug Discovery and Preclinical CRO Basic Information
9.11.2 Evotec Drug Discovery and Preclinical CRO Product Overview
9.11.3 Evotec Drug Discovery and Preclinical CRO Product Market Performance
9.11.4 Evotec Business Overview
9.11.5 Evotec Recent Developments
9.12 Medicilon
9.12.1 Medicilon Drug Discovery and Preclinical CRO Basic Information
9.12.2 Medicilon Drug Discovery and Preclinical CRO Product Overview
9.12.3 Medicilon Drug Discovery and Preclinical CRO Product Market Performance
9.12.4 Medicilon Business Overview
9.12.5 Medicilon Recent Developments
9.13 Crown Bioscience
9.13.1 Crown Bioscience Drug Discovery and Preclinical CRO Basic Information
9.13.2 Crown Bioscience Drug Discovery and Preclinical CRO Product Overview
9.13.3 Crown Bioscience Drug Discovery and Preclinical CRO Product Market Performance
9.13.4 Crown Bioscience Business Overview
9.13.5 Crown Bioscience Recent Developments
9.14 Champions Oncology
9.14.1 Champions Oncology Drug Discovery and Preclinical CRO Basic Information
9.14.2 Champions Oncology Drug Discovery and Preclinical CRO Product Overview
9.14.3 Champions Oncology Drug Discovery and Preclinical CRO Product Market Performance
9.14.4 Champions Oncology Business Overview
9.14.5 Champions Oncology Recent Developments
9.15 Frontage Laboratories
9.15.1 Frontage Laboratories Drug Discovery and Preclinical CRO Basic Information
9.15.2 Frontage Laboratories Drug Discovery and Preclinical CRO Product Overview
9.15.3 Frontage Laboratories Drug Discovery and Preclinical CRO Product Market Performance
9.15.4 Frontage Laboratories Business Overview
9.15.5 Frontage Laboratories Recent Developments
9.16 Viva Biotech
9.16.1 Viva Biotech Drug Discovery and Preclinical CRO Basic Information
9.16.2 Viva Biotech Drug Discovery and Preclinical CRO Product Overview
9.16.3 Viva Biotech Drug Discovery and Preclinical CRO Product Market Performance
9.16.4 Viva Biotech Business Overview
9.16.5 Viva Biotech Recent Developments
9.17 Hitgen Inc.
9.17.1 Hitgen Inc. Drug Discovery and Preclinical CRO Basic Information
9.17.2 Hitgen Inc. Drug Discovery and Preclinical CRO Product Overview
9.17.3 Hitgen Inc. Drug Discovery and Preclinical CRO Product Market Performance
9.17.4 Hitgen Inc. Business Overview
9.17.5 Hitgen Inc. Recent Developments
9.18 Shanghai Innostar
9.18.1 Shanghai Innostar Drug Discovery and Preclinical CRO Basic Information
9.18.2 Shanghai Innostar Drug Discovery and Preclinical CRO Product Overview
9.18.3 Shanghai Innostar Drug Discovery and Preclinical CRO Product Market Performance
9.18.4 Shanghai Innostar Business Overview
9.18.5 Shanghai Innostar Recent Developments
10 DRUG DISCOVERY AND PRECLINICAL CRO REGIONAL MARKET FORECAST
10.1 Global Drug Discovery and Preclinical CRO Market Size Forecast
10.2 Global Drug Discovery and Preclinical CRO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Drug Discovery and Preclinical CRO Market Size Forecast by Country
10.2.3 Asia Pacific Drug Discovery and Preclinical CRO Market Size Forecast by Region
10.2.4 South America Drug Discovery and Preclinical CRO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Drug Discovery and Preclinical CRO by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Drug Discovery and Preclinical CRO Market Forecast by Type (2025-2030)
11.2 Global Drug Discovery and Preclinical CRO Market Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Drug Discovery and Preclinical CRO Market Size Comparison by Region (M USD)
Table 5. Global Drug Discovery and Preclinical CRO Revenue (M USD) by Company (2019-2024)
Table 6. Global Drug Discovery and Preclinical CRO Revenue Share by Company (2019-2024)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Discovery and Preclinical CRO as of 2022)
Table 8. Company Drug Discovery and Preclinical CRO Market Size Sites and Area Served
Table 9. Company Drug Discovery and Preclinical CRO Product Type
Table 10. Global Drug Discovery and Preclinical CRO Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of Drug Discovery and Preclinical CRO
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Drug Discovery and Preclinical CRO Market Challenges
Table 18. Global Drug Discovery and Preclinical CRO Market Size by Type (M USD)
Table 19. Global Drug Discovery and Preclinical CRO Market Size (M USD) by Type (2019-2024)
Table 20. Global Drug Discovery and Preclinical CRO Market Size Share by Type (2019-2024)
Table 21. Global Drug Discovery and Preclinical CRO Market Size Growth Rate by Type (2019-2024)
Table 22. Global Drug Discovery and Preclinical CRO Market Size by Application
Table 23. Global Drug Discovery and Preclinical CRO Market Size by Application (2019-2024) & (M USD)
Table 24. Global Drug Discovery and Preclinical CRO Market Share by Application (2019-2024)
Table 25. Global Drug Discovery and Preclinical CRO Market Size Growth Rate by Application (2019-2024)
Table 26. Global Drug Discovery and Preclinical CRO Market Size by Region (2019-2024) & (M USD)
Table 27. Global Drug Discovery and Preclinical CRO Market Size Market Share by Region (2019-2024)
Table 28. North America Drug Discovery and Preclinical CRO Market Size by Country (2019-2024) & (M USD)
Table 29. Europe Drug Discovery and Preclinical CRO Market Size by Country (2019-2024) & (M USD)
Table 30. Asia Pacific Drug Discovery and Preclinical CRO Market Size by Region (2019-2024) & (M USD)
Table 31. South America Drug Discovery and Preclinical CRO Market Size by Country (2019-2024) & (M USD)
Table 32. Middle East and Africa Drug Discovery and Preclinical CRO Market Size by Region (2019-2024) & (M USD)
Table 33. Charles River Drug Discovery and Preclinical CRO Basic Information
Table 34. Charles River Drug Discovery and Preclinical CRO Product Overview
Table 35. Charles River Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 36. Charles River Drug Discovery and Preclinical CRO SWOT Analysis
Table 37. Charles River Business Overview
Table 38. Charles River Recent Developments
Table 39. Wuxi AppTec Drug Discovery and Preclinical CRO Basic Information
Table 40. Wuxi AppTec Drug Discovery and Preclinical CRO Product Overview
Table 41. Wuxi AppTec Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 42. Charles River Drug Discovery and Preclinical CRO SWOT Analysis
Table 43. Wuxi AppTec Business Overview
Table 44. Wuxi AppTec Recent Developments
Table 45. Labcorp Drug Discovery and Preclinical CRO Basic Information
Table 46. Labcorp Drug Discovery and Preclinical CRO Product Overview
Table 47. Labcorp Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 48. Charles River Drug Discovery and Preclinical CRO SWOT Analysis
Table 49. Labcorp Business Overview
Table 50. Labcorp Recent Developments
Table 51. Eurofins Scientific Drug Discovery and Preclinical CRO Basic Information
Table 52. Eurofins Scientific Drug Discovery and Preclinical CRO Product Overview
Table 53. Eurofins Scientific Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 54. Eurofins Scientific Business Overview
Table 55. Eurofins Scientific Recent Developments
Table 56. PPD Drug Discovery and Preclinical CRO Basic Information
Table 57. PPD Drug Discovery and Preclinical CRO Product Overview
Table 58. PPD Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 59. PPD Business Overview
Table 60. PPD Recent Developments
Table 61. ICON plc Drug Discovery and Preclinical CRO Basic Information
Table 62. ICON plc Drug Discovery and Preclinical CRO Product Overview
Table 63. ICON plc Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 64. ICON plc Business Overview
Table 65. ICON plc Recent Developments
Table 66. Pharmaron Drug Discovery and Preclinical CRO Basic Information
Table 67. Pharmaron Drug Discovery and Preclinical CRO Product Overview
Table 68. Pharmaron Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 69. Pharmaron Business Overview
Table 70. Pharmaron Recent Developments
Table 71. Inotiv Drug Discovery and Preclinical CRO Basic Information
Table 72. Inotiv Drug Discovery and Preclinical CRO Product Overview
Table 73. Inotiv Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 74. Inotiv Business Overview
Table 75. Inotiv Recent Developments
Table 76. ChemPartner Drug Discovery and Preclinical CRO Basic Information
Table 77. ChemPartner Drug Discovery and Preclinical CRO Product Overview
Table 78. ChemPartner Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 79. ChemPartner Business Overview
Table 80. ChemPartner Recent Developments
Table 81. JOINN Laboratories Drug Discovery and Preclinical CRO Basic Information
Table 82. JOINN Laboratories Drug Discovery and Preclinical CRO Product Overview
Table 83. JOINN Laboratories Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 84. JOINN Laboratories Business Overview
Table 85. JOINN Laboratories Recent Developments
Table 86. Evotec Drug Discovery and Preclinical CRO Basic Information
Table 87. Evotec Drug Discovery and Preclinical CRO Product Overview
Table 88. Evotec Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 89. Evotec Business Overview
Table 90. Evotec Recent Developments
Table 91. Medicilon Drug Discovery and Preclinical CRO Basic Information
Table 92. Medicilon Drug Discovery and Preclinical CRO Product Overview
Table 93. Medicilon Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 94. Medicilon Business Overview
Table 95. Medicilon Recent Developments
Table 96. Crown Bioscience Drug Discovery and Preclinical CRO Basic Information
Table 97. Crown Bioscience Drug Discovery and Preclinical CRO Product Overview
Table 98. Crown Bioscience Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 99. Crown Bioscience Business Overview
Table 100. Crown Bioscience Recent Developments
Table 101. Champions Oncology Drug Discovery and Preclinical CRO Basic Information
Table 102. Champions Oncology Drug Discovery and Preclinical CRO Product Overview
Table 103. Champions Oncology Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 104. Champions Oncology Business Overview
Table 105. Champions Oncology Recent Developments
Table 106. Frontage Laboratories Drug Discovery and Preclinical CRO Basic Information
Table 107. Frontage Laboratories Drug Discovery and Preclinical CRO Product Overview
Table 108. Frontage Laboratories Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 109. Frontage Laboratories Business Overview
Table 110. Frontage Laboratories Recent Developments
Table 111. Viva Biotech Drug Discovery and Preclinical CRO Basic Information
Table 112. Viva Biotech Drug Discovery and Preclinical CRO Product Overview
Table 113. Viva Biotech Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 114. Viva Biotech Business Overview
Table 115. Viva Biotech Recent Developments
Table 116. Hitgen Inc. Drug Discovery and Preclinical CRO Basic Information
Table 117. Hitgen Inc. Drug Discovery and Preclinical CRO Product Overview
Table 118. Hitgen Inc. Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 119. Hitgen Inc. Business Overview
Table 120. Hitgen Inc. Recent Developments
Table 121. Shanghai Innostar Drug Discovery and Preclinical CRO Basic Information
Table 122. Shanghai Innostar Drug Discovery and Preclinical CRO Product Overview
Table 123. Shanghai Innostar Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 124. Shanghai Innostar Business Overview
Table 125. Shanghai Innostar Recent Developments
Table 126. Global Drug Discovery and Preclinical CRO Market Size Forecast by Region (2025-2030) & (M USD)
Table 127. North America Drug Discovery and Preclinical CRO Market Size Forecast by Country (2025-2030) & (M USD)
Table 128. Europe Drug Discovery and Preclinical CRO Market Size Forecast by Country (2025-2030) & (M USD)
Table 129. Asia Pacific Drug Discovery and Preclinical CRO Market Size Forecast by Region (2025-2030) & (M USD)
Table 130. South America Drug Discovery and Preclinical CRO Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Drug Discovery and Preclinical CRO Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Global Drug Discovery and Preclinical CRO Market Size Forecast by Type (2025-2030) & (M USD)
Table 133. Global Drug Discovery and Preclinical CRO Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Drug Discovery and Preclinical CRO Market Size Comparison by Region (M USD)
Table 5. Global Drug Discovery and Preclinical CRO Revenue (M USD) by Company (2019-2024)
Table 6. Global Drug Discovery and Preclinical CRO Revenue Share by Company (2019-2024)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Discovery and Preclinical CRO as of 2022)
Table 8. Company Drug Discovery and Preclinical CRO Market Size Sites and Area Served
Table 9. Company Drug Discovery and Preclinical CRO Product Type
Table 10. Global Drug Discovery and Preclinical CRO Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Value Chain Map of Drug Discovery and Preclinical CRO
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Drug Discovery and Preclinical CRO Market Challenges
Table 18. Global Drug Discovery and Preclinical CRO Market Size by Type (M USD)
Table 19. Global Drug Discovery and Preclinical CRO Market Size (M USD) by Type (2019-2024)
Table 20. Global Drug Discovery and Preclinical CRO Market Size Share by Type (2019-2024)
Table 21. Global Drug Discovery and Preclinical CRO Market Size Growth Rate by Type (2019-2024)
Table 22. Global Drug Discovery and Preclinical CRO Market Size by Application
Table 23. Global Drug Discovery and Preclinical CRO Market Size by Application (2019-2024) & (M USD)
Table 24. Global Drug Discovery and Preclinical CRO Market Share by Application (2019-2024)
Table 25. Global Drug Discovery and Preclinical CRO Market Size Growth Rate by Application (2019-2024)
Table 26. Global Drug Discovery and Preclinical CRO Market Size by Region (2019-2024) & (M USD)
Table 27. Global Drug Discovery and Preclinical CRO Market Size Market Share by Region (2019-2024)
Table 28. North America Drug Discovery and Preclinical CRO Market Size by Country (2019-2024) & (M USD)
Table 29. Europe Drug Discovery and Preclinical CRO Market Size by Country (2019-2024) & (M USD)
Table 30. Asia Pacific Drug Discovery and Preclinical CRO Market Size by Region (2019-2024) & (M USD)
Table 31. South America Drug Discovery and Preclinical CRO Market Size by Country (2019-2024) & (M USD)
Table 32. Middle East and Africa Drug Discovery and Preclinical CRO Market Size by Region (2019-2024) & (M USD)
Table 33. Charles River Drug Discovery and Preclinical CRO Basic Information
Table 34. Charles River Drug Discovery and Preclinical CRO Product Overview
Table 35. Charles River Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 36. Charles River Drug Discovery and Preclinical CRO SWOT Analysis
Table 37. Charles River Business Overview
Table 38. Charles River Recent Developments
Table 39. Wuxi AppTec Drug Discovery and Preclinical CRO Basic Information
Table 40. Wuxi AppTec Drug Discovery and Preclinical CRO Product Overview
Table 41. Wuxi AppTec Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 42. Charles River Drug Discovery and Preclinical CRO SWOT Analysis
Table 43. Wuxi AppTec Business Overview
Table 44. Wuxi AppTec Recent Developments
Table 45. Labcorp Drug Discovery and Preclinical CRO Basic Information
Table 46. Labcorp Drug Discovery and Preclinical CRO Product Overview
Table 47. Labcorp Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 48. Charles River Drug Discovery and Preclinical CRO SWOT Analysis
Table 49. Labcorp Business Overview
Table 50. Labcorp Recent Developments
Table 51. Eurofins Scientific Drug Discovery and Preclinical CRO Basic Information
Table 52. Eurofins Scientific Drug Discovery and Preclinical CRO Product Overview
Table 53. Eurofins Scientific Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 54. Eurofins Scientific Business Overview
Table 55. Eurofins Scientific Recent Developments
Table 56. PPD Drug Discovery and Preclinical CRO Basic Information
Table 57. PPD Drug Discovery and Preclinical CRO Product Overview
Table 58. PPD Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 59. PPD Business Overview
Table 60. PPD Recent Developments
Table 61. ICON plc Drug Discovery and Preclinical CRO Basic Information
Table 62. ICON plc Drug Discovery and Preclinical CRO Product Overview
Table 63. ICON plc Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 64. ICON plc Business Overview
Table 65. ICON plc Recent Developments
Table 66. Pharmaron Drug Discovery and Preclinical CRO Basic Information
Table 67. Pharmaron Drug Discovery and Preclinical CRO Product Overview
Table 68. Pharmaron Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 69. Pharmaron Business Overview
Table 70. Pharmaron Recent Developments
Table 71. Inotiv Drug Discovery and Preclinical CRO Basic Information
Table 72. Inotiv Drug Discovery and Preclinical CRO Product Overview
Table 73. Inotiv Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 74. Inotiv Business Overview
Table 75. Inotiv Recent Developments
Table 76. ChemPartner Drug Discovery and Preclinical CRO Basic Information
Table 77. ChemPartner Drug Discovery and Preclinical CRO Product Overview
Table 78. ChemPartner Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 79. ChemPartner Business Overview
Table 80. ChemPartner Recent Developments
Table 81. JOINN Laboratories Drug Discovery and Preclinical CRO Basic Information
Table 82. JOINN Laboratories Drug Discovery and Preclinical CRO Product Overview
Table 83. JOINN Laboratories Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 84. JOINN Laboratories Business Overview
Table 85. JOINN Laboratories Recent Developments
Table 86. Evotec Drug Discovery and Preclinical CRO Basic Information
Table 87. Evotec Drug Discovery and Preclinical CRO Product Overview
Table 88. Evotec Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 89. Evotec Business Overview
Table 90. Evotec Recent Developments
Table 91. Medicilon Drug Discovery and Preclinical CRO Basic Information
Table 92. Medicilon Drug Discovery and Preclinical CRO Product Overview
Table 93. Medicilon Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 94. Medicilon Business Overview
Table 95. Medicilon Recent Developments
Table 96. Crown Bioscience Drug Discovery and Preclinical CRO Basic Information
Table 97. Crown Bioscience Drug Discovery and Preclinical CRO Product Overview
Table 98. Crown Bioscience Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 99. Crown Bioscience Business Overview
Table 100. Crown Bioscience Recent Developments
Table 101. Champions Oncology Drug Discovery and Preclinical CRO Basic Information
Table 102. Champions Oncology Drug Discovery and Preclinical CRO Product Overview
Table 103. Champions Oncology Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 104. Champions Oncology Business Overview
Table 105. Champions Oncology Recent Developments
Table 106. Frontage Laboratories Drug Discovery and Preclinical CRO Basic Information
Table 107. Frontage Laboratories Drug Discovery and Preclinical CRO Product Overview
Table 108. Frontage Laboratories Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 109. Frontage Laboratories Business Overview
Table 110. Frontage Laboratories Recent Developments
Table 111. Viva Biotech Drug Discovery and Preclinical CRO Basic Information
Table 112. Viva Biotech Drug Discovery and Preclinical CRO Product Overview
Table 113. Viva Biotech Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 114. Viva Biotech Business Overview
Table 115. Viva Biotech Recent Developments
Table 116. Hitgen Inc. Drug Discovery and Preclinical CRO Basic Information
Table 117. Hitgen Inc. Drug Discovery and Preclinical CRO Product Overview
Table 118. Hitgen Inc. Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 119. Hitgen Inc. Business Overview
Table 120. Hitgen Inc. Recent Developments
Table 121. Shanghai Innostar Drug Discovery and Preclinical CRO Basic Information
Table 122. Shanghai Innostar Drug Discovery and Preclinical CRO Product Overview
Table 123. Shanghai Innostar Drug Discovery and Preclinical CRO Revenue (M USD) and Gross Margin (2019-2024)
Table 124. Shanghai Innostar Business Overview
Table 125. Shanghai Innostar Recent Developments
Table 126. Global Drug Discovery and Preclinical CRO Market Size Forecast by Region (2025-2030) & (M USD)
Table 127. North America Drug Discovery and Preclinical CRO Market Size Forecast by Country (2025-2030) & (M USD)
Table 128. Europe Drug Discovery and Preclinical CRO Market Size Forecast by Country (2025-2030) & (M USD)
Table 129. Asia Pacific Drug Discovery and Preclinical CRO Market Size Forecast by Region (2025-2030) & (M USD)
Table 130. South America Drug Discovery and Preclinical CRO Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Drug Discovery and Preclinical CRO Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Global Drug Discovery and Preclinical CRO Market Size Forecast by Type (2025-2030) & (M USD)
Table 133. Global Drug Discovery and Preclinical CRO Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Industrial Chain of Drug Discovery and Preclinical CRO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drug Discovery and Preclinical CRO Market Size (M USD), 2019-2030
Figure 5. Global Drug Discovery and Preclinical CRO Market Size (M USD) (2019-2030)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Drug Discovery and Preclinical CRO Market Size by Country (M USD)
Figure 10. Global Drug Discovery and Preclinical CRO Revenue Share by Company in 2023
Figure 11. Drug Discovery and Preclinical CRO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by Drug Discovery and Preclinical CRO Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global Drug Discovery and Preclinical CRO Market Share by Type
Figure 15. Market Size Share of Drug Discovery and Preclinical CRO by Type (2019-2024)
Figure 16. Market Size Market Share of Drug Discovery and Preclinical CRO by Type in 2022
Figure 17. Global Drug Discovery and Preclinical CRO Market Size Growth Rate by Type (2019-2024)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global Drug Discovery and Preclinical CRO Market Share by Application
Figure 20. Global Drug Discovery and Preclinical CRO Market Share by Application (2019-2024)
Figure 21. Global Drug Discovery and Preclinical CRO Market Share by Application in 2022
Figure 22. Global Drug Discovery and Preclinical CRO Market Size Growth Rate by Application (2019-2024)
Figure 23. Global Drug Discovery and Preclinical CRO Market Size Market Share by Region (2019-2024)
Figure 24. North America Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 25. North America Drug Discovery and Preclinical CRO Market Size Market Share by Country in 2023
Figure 26. U.S. Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 27. Canada Drug Discovery and Preclinical CRO Market Size (M USD) and Growth Rate (2019-2024)
Figure 28. Mexico Drug Discovery and Preclinical CRO Market Size (Units) and Growth Rate (2019-2024)
Figure 29. Europe Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 30. Europe Drug Discovery and Preclinical CRO Market Size Market Share by Country in 2023
Figure 31. Germany Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 32. France Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 33. U.K. Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 34. Italy Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 35. Russia Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 36. Asia Pacific Drug Discovery and Preclinical CRO Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific Drug Discovery and Preclinical CRO Market Size Market Share by Region in 2023
Figure 38. China Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 39. Japan Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 40. South Korea Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 41. India Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 42. Southeast Asia Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 43. South America Drug Discovery and Preclinical CRO Market Size and Growth Rate (M USD)
Figure 44. South America Drug Discovery and Preclinical CRO Market Size Market Share by Country in 2023
Figure 45. Brazil Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 46. Argentina Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 47. Columbia Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 48. Middle East and Africa Drug Discovery and Preclinical CRO Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa Drug Discovery and Preclinical CRO Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 51. UAE Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 52. Egypt Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 53. Nigeria Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 54. South Africa Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 55. Global Drug Discovery and Preclinical CRO Market Size Forecast by Value (2019-2030) & (M USD)
Figure 56. Global Drug Discovery and Preclinical CRO Market Share Forecast by Type (2025-2030)
Figure 57. Global Drug Discovery and Preclinical CRO Market Share Forecast by Application (2025-2030)
Figure 1. Industrial Chain of Drug Discovery and Preclinical CRO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drug Discovery and Preclinical CRO Market Size (M USD), 2019-2030
Figure 5. Global Drug Discovery and Preclinical CRO Market Size (M USD) (2019-2030)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Drug Discovery and Preclinical CRO Market Size by Country (M USD)
Figure 10. Global Drug Discovery and Preclinical CRO Revenue Share by Company in 2023
Figure 11. Drug Discovery and Preclinical CRO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 12. The Global 5 and 10 Largest Players: Market Share by Drug Discovery and Preclinical CRO Revenue in 2023
Figure 13. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 14. Global Drug Discovery and Preclinical CRO Market Share by Type
Figure 15. Market Size Share of Drug Discovery and Preclinical CRO by Type (2019-2024)
Figure 16. Market Size Market Share of Drug Discovery and Preclinical CRO by Type in 2022
Figure 17. Global Drug Discovery and Preclinical CRO Market Size Growth Rate by Type (2019-2024)
Figure 18. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 19. Global Drug Discovery and Preclinical CRO Market Share by Application
Figure 20. Global Drug Discovery and Preclinical CRO Market Share by Application (2019-2024)
Figure 21. Global Drug Discovery and Preclinical CRO Market Share by Application in 2022
Figure 22. Global Drug Discovery and Preclinical CRO Market Size Growth Rate by Application (2019-2024)
Figure 23. Global Drug Discovery and Preclinical CRO Market Size Market Share by Region (2019-2024)
Figure 24. North America Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 25. North America Drug Discovery and Preclinical CRO Market Size Market Share by Country in 2023
Figure 26. U.S. Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 27. Canada Drug Discovery and Preclinical CRO Market Size (M USD) and Growth Rate (2019-2024)
Figure 28. Mexico Drug Discovery and Preclinical CRO Market Size (Units) and Growth Rate (2019-2024)
Figure 29. Europe Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 30. Europe Drug Discovery and Preclinical CRO Market Size Market Share by Country in 2023
Figure 31. Germany Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 32. France Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 33. U.K. Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 34. Italy Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 35. Russia Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 36. Asia Pacific Drug Discovery and Preclinical CRO Market Size and Growth Rate (M USD)
Figure 37. Asia Pacific Drug Discovery and Preclinical CRO Market Size Market Share by Region in 2023
Figure 38. China Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 39. Japan Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 40. South Korea Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 41. India Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 42. Southeast Asia Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 43. South America Drug Discovery and Preclinical CRO Market Size and Growth Rate (M USD)
Figure 44. South America Drug Discovery and Preclinical CRO Market Size Market Share by Country in 2023
Figure 45. Brazil Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 46. Argentina Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 47. Columbia Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 48. Middle East and Africa Drug Discovery and Preclinical CRO Market Size and Growth Rate (M USD)
Figure 49. Middle East and Africa Drug Discovery and Preclinical CRO Market Size Market Share by Region in 2023
Figure 50. Saudi Arabia Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 51. UAE Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 52. Egypt Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 53. Nigeria Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 54. South Africa Drug Discovery and Preclinical CRO Market Size and Growth Rate (2019-2024) & (M USD)
Figure 55. Global Drug Discovery and Preclinical CRO Market Size Forecast by Value (2019-2030) & (M USD)
Figure 56. Global Drug Discovery and Preclinical CRO Market Share Forecast by Type (2025-2030)
Figure 57. Global Drug Discovery and Preclinical CRO Market Share Forecast by Application (2025-2030)
